|
|
The Life Insurance Market
|
A new cancer drug could lead to a breakthrough in the fight against advanced melanoma in news that reinforces the importance of critical illness cover.
According to a report in Nature News the new genetically targeted drug represents a major shift in the way that skin cancer is treated and could dramatically extend the lifetimes of those affected.
Clinical trials have indicated that the drug slows down the way the disease spreads though the body and could have wider implications for cancer treatment more generally.
If you're looking to protect your family financially from the problems that cancer can cause, then getting the right critical illness cover is a vital first step.
--
0
comments:
-
Post your own comment
|
|
|